These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2006-001084-27 Phase I/II study of prevention of Colorectal Cancer CRC with Allopurinol in High-Risk Subjects not-yet-due
Ongoing 2007-007740-10 Randomized placebo-controlled phase III trial of low-dose tamoxifen women whit IntraEphitelial Neoplasia(IEN) not-yet-due
Ongoing 2008-005206-39 Pilot Study: Iron-chelating treatment in patients with Neurodegeneration with Brain Iron Accumulation (NBIA). not-yet-due
Ongoing 2009-010088-17 Whole liver iron overload measured by the biosusceptometer Magnetic Iron Detector (MID) in thalassemia and MDS patients treated with deferasirox not-yet-due
Ongoing 2010-018456-27 Efficacia diagnostica della metodica 18F-DOPA-PET/TC nello studio del Neuroblastoma: confronto con scintigrafia 123I-MIBG. not-yet-due
Ongoing 2012-005398-30 Diagnostic efficacy and prognostic method [18F] DOPA-PET/CT in not-yet-due
Ongoing 2013-000287-29 EARLY PREDICTION OF EFFICACY OF ENDOCRINE THERAPY IN BREAST CANCER: not-yet-due
Completed, but no date 2014-005140-18 Diagnostic and clinical value of fused 64CuCl2-PET/MRI in prostate cancer relapse. Comparison with multiparametric MRI (mMRI) and 18F-Choline-PET/MRI bad-data
Ongoing 2015-004824-77 A randomized, phase II, double-blind, placebo-controlled, multicenter, 2x2 factorial design biomarker tertiary prevention trial of low-dose aspirin and metformin in resected stage I-III colorectal can... not-yet-due
Ongoing 2018-000693-30 EXemestane in Progesterone and/or Estrogen receptor positive epithelial ovarian cancer. A Randomized phase III Trial, EXPERT. not-yet-due